Forced randomization: the what, why, and how

Kerstine Carter,Olga Kuznetsova,Volodymyr Anisimov,Johannes Krisam,Colin Scherer,Yevgen Ryeznik,Oleksandr Sverdlov
DOI: https://doi.org/10.1186/s12874-024-02340-0
2024-10-10
BMC Medical Research Methodology
Abstract:When running a randomized controlled trial (RCT), a clinical site may face a situation when an eligible trial participant is to be randomized to the treatment that is not available at the site. In this case, there are two options: not to enroll the participant, or, without disclosing to the site, allocate the participant to a treatment arm with drug available at the site using a built-in feature of the interactive response technology (IRT). In the latter case, one has employed a "forced randomization" (FR). There seems to be an industry-wide consensus that using FR can be acceptable in confirmatory trials provided there are "not too many" instances of forcing. A better understanding of statistical properties of FR is warranted.
health care sciences & services
What problem does this paper attempt to address?